# Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

> **NCT00214981** · PHASE3 · COMPLETED · sponsor: **Cephalon**

## Conditions studied

- Attention Deficit/Hyperactivity Disorder
- ADHD

## Interventions

- **DRUG:** Modafinil

## Key facts

- **NCT ID:** NCT00214981
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** — (—)
- **Last updated:** 2012-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214981, "Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00214981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*